MARKET

NWPHF

NWPHF

Newron Phar
Grey
2.100
NaN%
Closed 09:30 03/27 EDT
OPEN
--
PREV CLOSE
2.800
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.100
52 WEEK LOW
2.100
MARKET CAP
41.92M
P/E (TTM)
1.308
1D
5D
1M
3M
1Y
5Y
1D
Newron Pharmaceuticals’ Earnings Call Signals Pivotal Year Ahead
TipRanks · 1d ago
Newron Pharma price target raised to CHF 48 from CHF 43 at H.C. Wainwright
TipRanks · 3d ago
Newron bolsters finances as Evenamide enters pivotal global Phase III
TipRanks · 4d ago
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
TipRanks · 4d ago
Newron to Highlight Phase III Evenamide Data at 2026 Schizophrenia Congress
TipRanks · 03/20 06:33
Newron extends EIB loan maturities to align financing with Evenamide milestones
TipRanks · 03/19 06:35
Newron refreshes board with CNS and capital markets experts ahead of AGM
TipRanks · 03/18 06:34
Newron Raises Up to EUR 38 Million to Advance Phase III Schizophrenia Drug Evenamide
TipRanks · 02/16 17:02
More
About NWPHF
Newron Pharmaceuticals SpA is an Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Its additional projects, such as HF0220 for neuroprotection, NW-3509 for the treatment of schizophrenia, as well as pruvanserin and sarizotan for treatment of CNS diseases, are at various stages of preclinical and clinical development.

Webull offers Newron Pharmaceuticals SpA stock information, including Grey: NWPHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NWPHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NWPHF stock methods without spending real money on the virtual paper trading platform.